Literature DB >> 17626254

Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism.

Frederick A Anderson1, Maxim Zayaruzny, John A Heit, Dogan Fidan, Alexander T Cohen.   

Abstract

Venous thromboembolism (VTE) is a major US health problem. However, the total number of US inpatients who are at risk for VTE is unknown. Our objective was to estimate the number of US acute-care hospital inpatients who were at risk for VTE according to criteria established by the Seventh American College of Chest Physicians (ACCP) Consensus Conference on Antithrombotic and Thrombolytic Therapy guidelines for VTE prevention. Using the 2003 Nationwide Inpatient Sample from the Healthcare Cost and Utilization Project (HCUP), patient diagnoses and procedures were examined to identify major surgery patients (age > or = 18 years, length of hospital stay > or = 2 days) and medical patients (age > or = 40 years, length of hospital stay > or = 2 days). ACCP guidelines were used to estimate the number of surgical and medical patients at risk of developing VTE. Of an estimated 38,220,659 discharges in 2003, 7,786,390 (20%) were surgical inpatients; 44% of which were at low risk for VTE, while 15%, 24%, and 17% were at moderate, high, and very high risk for VTE, respectively. Of the remaining 15,161,586 medical patients, 7,742,419 (51%) met ACCP VTE risk criteria. Over 12 million patients, comprising 31% of US hospital discharges in 2003, were at risk of VTE. Given the existence of internationally-accepted evidence-based guidelines for prevention of VTE, research is required to establish if this patient population is receiving recommended VTE prophylaxis. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626254     DOI: 10.1002/ajh.20983

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  69 in total

1.  Inferior vena cava filtration in the management of venous thromboembolism: filtering the data.

Authors:  Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

Review 2.  A systematic review of Cochrane anticoagulation reviews.

Authors:  David Keith Cundiff
Journal:  Medscape J Med       Date:  2009-01-06

3.  A validated risk model to predict 90-day VTE events in postsurgical patients.

Authors:  Christopher J Pannucci; Sandra Laird; Justin B Dimick; Darrell A Campbell; Peter K Henke
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

4.  Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States.

Authors:  Holly Guy; Vicki Laskier; Mark Fisher; W Richey Neuman; Iwona Bucior; Steven Deitelzweig; Alexander T Cohen
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

Review 5.  Rationale supporting an "opt-out" policy for pharmacological venous thromboembolism prophylaxis in hospitalized medical patients.

Authors:  Samuel Z Goldhaber
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

6.  Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism: a case control study.

Authors:  Jason Suh; Amishi Desai; Anish Desai; Josephine Dela Cruz; Anusiyanthan Mariampillai; Alexander Hindenburg
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

Review 7.  Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Matthew J Koster; Charat Thongprayoon; Kenneth J Warrington
Journal:  Clin Rheumatol       Date:  2016-08-30       Impact factor: 2.980

8.  Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults.

Authors:  Nels Olson; Ellen S O'Meara; Nancy S Jenny; Aaron R Folsom; Edwin G Bovill; Curt D Furberg; Susan R Heckbert; Bruce M Psaty; Mary Cushman
Journal:  Am J Hematol       Date:  2008-07       Impact factor: 10.047

9.  Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.

Authors:  Andrea J Darzi; Samer G Karam; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Mary Cushman; Michael K Gould; Lawrence Mbuagbaw; Frederick A Spencer; Alex C Spyropoulos; Michael B Streiff; Scott Woller; Neil A Zakai; Federico Germini; Marta Rigoni; Arnav Agarwal; Rami Z Morsi; Alfonso Iorio; Elie A Akl; Holger J Schünemann
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

10.  Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients.

Authors:  Irene Yu; Leo Chen; Jenny Y Ruan; Jennifer T Chang; Winson Y Cheung
Journal:  Support Care Cancer       Date:  2015-08-19       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.